NYSE:DGXHealthcare
Should Investors Reevaluate Quest Diagnostics After Positive Earnings and 20% One Year Return?
Thinking about what to do with Quest Diagnostics stock? You are not alone. Whether you are a seasoned shareholder or just watching from the sidelines, recent market movements have made this healthcare name hard to ignore. In the past year alone, Quest Diagnostics has delivered a total return around 20%, and the stock is up about 19% year-to-date. That is not bad for a company many still see as a mainstay in the diagnostics sector. Over the past five years, shares have practically doubled,...